|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 February 2001, Vol. 97, No. 4, pp. 858-862
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Risk of recurrent venous thrombosis in children with
combined prothrombotic risk factors
Ulrike Nowak-Göttl,
Ralf Junker,
Wolfhart Kreuz,
Arnold von
Eckardstein,
Andrea Kosch,
Natascha Nohe,
Rosemarie Schobess, and
Silke Ehrenforth for the Childhood Thrombophilia
Study Group
From the Department of Pediatric Hematology/Oncology,
University of Münster, Germany; Department of Clinical Chemistry
and Laboratory Medicine, and Department of Arteriosclerosis Research,
University of Münster, Germany; Department of Pediatric
Hematology/Oncology, University of Frankfurt am Main, Germany;
University Children's Hospital, Munich, Germany; Department of
Pediatric Hematology/Oncology, University of Halle an der Saale,
Germany; Department of Internal Medicine, University of Frankfurt,
Germany.
After a first episode of spontaneous venous thromboembolism (VTE),
the risk of recurrence persists for many years. However, comprehensive
data about the risk of recurrence in pediatric patients have hitherto
not been reported. Thus, this study evaluated the risk of recurrent VTE
among children in relation to the presence of single or
combined-inherited and/or acquired causes of thrombophilia. A total of
301 patients aged neonate to 18 years (median, 6 years) who were
referred for an objectively confirmed first episode of spontaneous VTE
were followed prospectively for a median time of 7 years (range, 6 months to 15 years) after withdrawal of anticoagulation. All patients
were studied for established acquired and inherited causes of
thromboembolism. With reference to all 301 patients, one single
prothrombotic risk factor was found in 176 subjects (58.5%), whereas
combined defects were found in 20.6% (n = 62). Recurrent VTE
occurred in 64 patients (21.3%) within a median time of 3.5 years
(range, 7 weeks to 15 years) after withdrawal of anticoagulation, with
a significantly shorter cumulative thrombosis-free survival in children
carrying combined defects (P < .0001; chi-square, 42.2).
The factor V G1691A mutation was present in the majority of patients
with recurrent VTE. Including genetic defects, gender, and acquired
risk factors, multivariate analysis showed that only the presence of
prothrombotic defects increases the risk of recurrent VTE (single
defect: odds ratio [OR], 4.6; 95% confidence interval [CI],
2.3-9.0; P < .0001; combined defect: OR, 24.0; 95% CI:
5.3-108.7; P < .0001). As a consequence of the data
presented here, it is suggested that screening for genetic risk factors
be done among pediatric patients with VTE.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Letter in Blood Online:
-
Increased Lipoprotein(a) levels are not a steady prothrombotic defect
- Wolfgang Korte, Jeanette Greiner, Andreas Feldges, and Walter F. Riesen
Blood 2001 98: 1993-1994.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
G. Young, M. Albisetti, M. Bonduel, L. Brandao, A. Chan, F. Friedrichs, N. A. Goldenberg, E. Grabowski, C. Heller, J. Journeycake, et al.
Impact of Inherited Thrombophilia on Venous Thromboembolism in Children: A Systematic Review and Meta-Analysis of Observational Studies
Circulation,
September 23, 2008;
118(13):
1373 - 1382.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Raffini
Thrombophilia in Children: Who to Test, How, When, and Why?
Hematology,
January 1, 2008;
2008(1):
228 - 235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Goldenberg
Thrombophilia States and Markers of Coagulation Activation in the Prediction of Pediatric Venous Thromboembolic Outcomes: A Comparative Analysis with Respect to Adult Evidence
Hematology,
January 1, 2008;
2008(1):
236 - 244.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Buffat, F. Boubred, F. Mondon, S. T. Chelbi, J.-M. Feuerstein, M. Lelievre-Pegorier, D. Vaiman, and U. Simeoni
Kidney Gene Expression Analysis in a Rat Model of Intrauterine Growth Restriction Reveals Massive Alterations of Coagulation Genes
Endocrinology,
November 1, 2007;
148(11):
5549 - 5557.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Lau, J. M. Stoffman, S. Williams, P. McCusker, L. Brandao, S. Patel, A. K.C. Chan, and for the Canadian Pediatric Thrombosis and Hemostas
Neonatal Renal Vein Thrombosis: Review of the English-Language Literature Between 1992 and 2006
Pediatrics,
November 1, 2007;
120(5):
e1278 - e1284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Goldenberg, J. D. Durham, R. Knapp-Clevenger, and M. J. Manco-Johnson
A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children
Blood,
July 1, 2007;
110(1):
45 - 53.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Bosler, J. Mattson, and D. Crisan
Phenotypic Heterogeneity in Patients with Homozygous Prothrombin 20210AA Genotype: A Paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology
J. Mol. Diagn.,
September 1, 2006;
8(4):
420 - 425.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Kreuz, M. Stoll, R. Junker, A. Heinecke, R. Schobess, K. Kurnik, R. Kelsch, and U. Nowak-Gottl
Familial Elevated Factor VIII in Children With Symptomatic Venous Thrombosis and Post-Thrombotic Syndrome: Results of a Multicenter Study
Arterioscler Thromb Vasc Biol,
August 1, 2006;
26(8):
1901 - 1906.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Parasuraman and S. Z. Goldhaber
Venous Thromboembolism in Children
Circulation,
January 17, 2006;
113(2):
e12 - e16.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Manco-Johnson
How I treat venous thrombosis in children
Blood,
January 1, 2006;
107(1):
21 - 29.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Goldenberg, R. Knapp-Clevenger, T. Hays, and M. J. Manco-Johnson
Lemierre's and Lemierre's-Like Syndromes in Children: Survival and Thromboembolic Outcomes
Pediatrics,
October 1, 2005;
116(4):
e543 - e548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Tzoufi, S. Giotopoulou, P. Papadimitriou, E. Dokou, N. I. Kolaitis, A. Siamopoulou, and G. Vartholomatos
Genetic Risk Factors Associated With Thrombosis in Children With Congenital Neurologic Disorders
J Child Neurol,
June 1, 2005;
20(6):
509 - 512.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Tzoufi, S. Giotopoulou, P. Papadimitriou, E. Dokou, N. I. Kolaitis, A. Siamopoulou, and G. Vartholomatos
Genetic Risk Factors Associated With Thrombosis in Children With Congenital Neurologic Disorders
J Child Neurol,
June 1, 2005;
20(6):
509 - 512.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. A. Connor
Factor V Leiden and Its Effect on Children With Cardiac Pathology
Journal of Pediatric Oncology Nursing,
May 1, 2005;
22(3):
176 - 181.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Berglund and R. Ramakrishnan
Lipoprotein(a): An Elusive Cardiovascular Risk Factor
Arterioscler Thromb Vasc Biol,
December 1, 2004;
24(12):
2219 - 2226.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Goldenberg, R. Knapp-Clevenger, M. J. Manco-Johnson, and the Mountain States Regional Thrombophilia Group
Elevated Plasma Factor VIII and D-Dimer Levels as Predictors of Poor Outcomes of Thrombosis in Children
N. Engl. J. Med.,
September 9, 2004;
351(11):
1081 - 1088.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kosch, E. Kuwertz-Broking, C. Heller, K. Kurnik, R. Schobess, and U. Nowak-Gottl
Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up
Blood,
September 1, 2004;
104(5):
1356 - 1360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. von Eckardstein
Is there a need for novel cardiovascular risk factors?
Nephrol. Dial. Transplant.,
April 1, 2004;
19(4):
761 - 765.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Marcovina, M. L. Koschinsky, J. J. Albers, and S. Skarlatos
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions
Clin. Chem.,
November 1, 2003;
49(11):
1785 - 1796.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R Zannolli, M A Mazzei, P Sacco, V Turchetti, T Amato, S Battistini, R Berardi, L Volterrani, V De Stefano, G Morgese, et al.
Posterior knee pain: primary symptom of a small non-occlusive venous clot
Arch. Dis. Child.,
August 1, 2003;
88(8):
728 - 729.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Palareti, C. Legnani, B. Cosmi, L. Valdre, B. Lunghi, F. Bernardi, and S. Coccheri
Predictive Value of D-Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital Thrombophilia
Circulation,
July 22, 2003;
108(3):
313 - 318.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. C. W. Wu and A. von Eckardstein
Androgens and Coronary Artery Disease
Endocr. Rev.,
April 1, 2003;
24(2):
183 - 217.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Tormene, P. Simioni, P. Prandoni, F. Franz, P. Zerbinati, G. Tognin, and A. Girolami
The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study
Blood,
September 18, 2002;
100(7):
2403 - 2405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Nowak-Gottl, R. Schobess, K. Kurnik, D. Schwabe, G. Fleischhack, R. Junker ;, W. Korte, J. Greiner, A. Feldges, and W. Riesen
Elevated lipoprotein(a) concentration is an independent risk factor of venous thromboembolism
Blood,
May 1, 2002;
99(9):
3476 - 3478.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Korte, J. Greiner, A. Feldges, and W. F. Riesen
Increased Lipoprotein(a) levels are not a steady prothrombotic defect
Blood,
September 15, 2001;
98(6):
1993 - 1994.
[Full Text]
[PDF]
|
|
|
|
|
